Proteomic landscape of tunneling nanotubes reveals CD9 and CD81 tetraspanins as key regulators.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
09 Sep 2024
Historique:
medline: 9 9 2024
pubmed: 9 9 2024
entrez: 9 9 2024
Statut: epublish

Résumé

Tunneling nanotubes (TNTs) are open actin- and membrane-based channels, connecting remote cells and allowing direct transfer of cellular material (e.g. vesicles, mRNAs, protein aggregates) from the cytoplasm to the cytoplasm. Although they are important especially, in pathological conditions (e.g. cancers, neurodegenerative diseases), their precise composition and their regulation were still poorly described. Here, using a biochemical approach allowing to separate TNTs from cell bodies and from extracellular vesicles and particles (EVPs), we obtained the full composition of TNTs compared to EVPs. We then focused on two major components of our proteomic data, the CD9 and CD81 tetraspanins, and further investigated their specific roles in TNT formation and function. We show that these two tetraspanins have distinct non-redundant functions: CD9 participates in stabilizing TNTs, whereas CD81 expression is required to allow the functional transfer of vesicles in the newly formed TNTs, possibly by regulating docking to or fusion with the opposing cell.

Identifiants

pubmed: 39250349
doi: 10.7554/eLife.99172
pii: 99172
doi:
pii:

Substances chimiques

Tetraspanin 28 0
Tetraspanin 29 0
CD81 protein, human 0
CD9 protein, human 0
Cd9 protein, mouse 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Institut National Du Cancer
ID : PLBIO18-103
Organisme : Fondation pour la Recherche Médicale
ID : FRM EQU202103012692
Organisme : Agence Nationale de la Recherche
ID : ANR-20-CE13-0032
Organisme : Agence Nationale de la Recherche
ID : ANR-21-CE35-0007
Organisme : Association France Alzheimer
ID : AAP PFA 2021 #6156

Informations de copyright

© 2024, Notario Manzano et al.

Déclaration de conflit d'intérêts

RN, TC, ER, EP, MM, CZ, CB No competing interests declared

Auteurs

Roberto Notario Manzano (R)

Membrane Traffic and Pathogenesis Unit, Department of Cell Biology and Infection, CNRS 18 UMR 3691, Institut Pasteur, Université Paris Cité, Paris, France.
Sorbonne Université, ED394 - Physiologie, Physiopathologie et Thérapeutique, Paris, France.

Thibault Chaze (T)

Proteomics Platform, Mass Spectrometry for Biology Unit, CNRS USR 2000, Institut Pasteur, Paris, France.

Eric Rubinstein (E)

Centre d'Immunologie et des Maladies Infectieuses, Inserm, CNRS, Sorbonne Université, CIMI-Paris, Paris, France.

Esthel Penard (E)

Ultrastructural BioImaging Core Facility (UBI), C2RT, Institut Pasteur, Université Paris Cité, Paris, France.

Mariette Matondo (M)

Proteomics Platform, Mass Spectrometry for Biology Unit, CNRS USR 2000, Institut Pasteur, Paris, France.

Chiara Zurzolo (C)

Membrane Traffic and Pathogenesis Unit, Department of Cell Biology and Infection, CNRS 18 UMR 3691, Institut Pasteur, Université Paris Cité, Paris, France.

Christel Brou (C)

Membrane Traffic and Pathogenesis Unit, Department of Cell Biology and Infection, CNRS 18 UMR 3691, Institut Pasteur, Université Paris Cité, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH